Sector Chart Arcus Biosciences, Inc.

Stocks

RCUS

US03969F1093

Biotechnology & Medical Research

Real-time Estimate Cboe BZX 17:48:12 11/09/2026 BST			5-day change	1st Jan Change
24.72 ^USD	-5.45%		-16.93%	+3.40%

09-09	Arcus Biosciences, Inc. Presents at Citigroup?s Biopharma Back to School Summit 2026, Sep-09-2026 10:40 AM
08-10	Arcus Biosciences' Casdatifan Therapy Could be Launched in 2028, Morgan Stanley Says	MT

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Sector Other Biotechnology & Medical Research

	Capi.	Sales Growth	Profitability	Finances	EV / Sales	P/E
ARCUS BIOSCIENCES, INC.	3.33B					-
LONZA GROUP AG	46.05B
REVOLUTION MEDICINES, INC.	43.59B	-	-	-	-	-
IQVIA HOLDINGS INC.	42.35B
BEONE MEDICINES AG	38.86B
CELLTRION, INC.	32.24B